- Healthcare Professionals
- Research
- Clinical trials
- glora study
2024-12-01T00:00:00.000+00:00
Ongoing
GLORA study
GLORA study
Haematology
A global multicenter, open-label, randomized phase 3 registrational study of lisaftoclax (APG-2575) in previously treated patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (GLORA study).
A global multicenter, open-label, randomized phase 3 registrational study of lisaftoclax (APG-2575) in previously treated patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (GLORA study).
Trial overview
Disease
Haematology
Topic
Diagnostics
Sponsor
Ascentage Pharma
Description
A global multicenter, open-label, randomized phase 3 registrational study of lisaftoclax (APG-2575) in previously treated patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (GLORA study).
Study details
For detailed information on this trial, please click here
Trial status
Opening January 2025
Location
Milton Keynes
:::
Principal Investigator
